{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T08:46:58Z","timestamp":1784278018587,"version":"3.55.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.smim.2022.101649","type":"journal-article","created":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:04:53Z","timestamp":1662163493000},"page":"101649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Diversity of NF-\u03baB signalling and inflammatory heterogeneity in Rheumatic Autoimmune Disease"],"prefix":"10.1016","volume":"58","author":[{"given":"Sotiria","family":"Manou-Stathopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles J.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9894","key":"10.1016\/j.smim.2022.101649_bib1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(13)61499-3","article-title":"Clinical aspects of autoimmune rheumatic diseases","volume":"382","author":"Goldblatt","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.smim.2022.101649_bib2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.it.2013.01.004","article-title":"Regulation of nuclear factor-\u03baB in autoimmunity","volume":"34","author":"Sun","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.smim.2022.101649_bib3","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target Ther."},{"issue":"6","key":"10.1016\/j.smim.2022.101649_bib4","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0092-8674(86)90807-X","article-title":"Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism","volume":"47","author":"Sen","year":"1986","journal-title":"Cell"},{"issue":"51","key":"10.1016\/j.smim.2022.101649_bib5","doi-asserted-by":"crossref","first-page":"6781","DOI":"10.1038\/sj.onc.1209944","article-title":"Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models","volume":"25","author":"Gerondakis","year":"2006","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.smim.2022.101649_bib6","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1073\/pnas.1120542109","article-title":"Genome-wide siRNA screen for mediators of NF-\u03baB activation","volume":"109","author":"Gewurz","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.smim.2022.101649_bib7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41423-019-0202-8","article-title":"Transcriptional and epigenetic regulation of immune tolerance: roles of the NF-\u03baB family members","volume":"16","author":"Zhang","year":"2019","journal-title":"Cell Mol. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2022.101649_bib8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/ni1330","article-title":"Lymphoid organ development: from ontogeny to neogenesis","volume":"7","author":"Drayton","year":"2006","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.smim.2022.101649_bib9","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1136\/annrheumdis-2019-215751","volume":"78","author":"Lliso-Ribera","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.smim.2022.101649_bib10","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/art.21062","article-title":"Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sj\u00f6gren's syndrome","volume":"52","author":"Barone","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.smim.2022.101649_bib11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1084\/jem.20151722","article-title":"IFN-\u03b3 receptor and STAT1 signaling in B cells are central to spontaneous germinal center formation and autoimmunity","volume":"213","author":"Domeier","year":"2016","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.smim.2022.101649_bib12","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1182\/blood-2005-06-2452","article-title":"Coordination between NF-kappaB family members p50 and p52 is essential for mediating LTbetaR signals in the development and organization of secondary lymphoid tissues","volume":"107","author":"Lo","year":"2006","journal-title":"Blood"},{"issue":"29","key":"10.1016\/j.smim.2022.101649_bib13","doi-asserted-by":"crossref","first-page":"30099","DOI":"10.1074\/jbc.M401428200","article-title":"Induction of p100 processing by NF-kappaB-inducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation","volume":"279","author":"Xiao","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"123","key":"10.1016\/j.smim.2022.101649_bib14","doi-asserted-by":"crossref","first-page":"ra41","DOI":"10.1126\/scisignal.2000778","article-title":"Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation","volume":"3","author":"Razani","year":"2010","journal-title":"Sci. Signal"},{"issue":"311","key":"10.1016\/j.smim.2022.101649_bib15","doi-asserted-by":"crossref","first-page":"ra13","DOI":"10.1126\/scisignal.2004557","article-title":"Noncanonical NF-\u03baB signaling is limited by classical NF-\u03baB activity","volume":"7","author":"Gray","year":"2014","journal-title":"Sci. Signal"},{"issue":"12","key":"10.1016\/j.smim.2022.101649_bib16","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/ng.2462","article-title":"High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis","volume":"44","author":"Eyre","year":"2012","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.smim.2022.101649_bib17","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1038\/s41467-019-12760-y","article-title":"GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways","volume":"10","author":"L\u00f3pez-Isac","year":"2019","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.smim.2022.101649_bib18","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/annrheumdis-2020-217663","article-title":"Genome-wide association study in a Korean population identifies six novel susceptibility loci for rheumatoid arthritis","volume":"79","author":"Kwon","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.smim.2022.101649_bib19","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ajhg.2015.10.019","article-title":"Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differences in their genetic architecture","volume":"97","author":"Stuart","year":"2015","journal-title":"Am. J. Hum. Genet."},{"issue":"12","key":"10.1016\/j.smim.2022.101649_bib20","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/ng.3434","article-title":"Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus","volume":"47","author":"Bentham","year":"2015","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.smim.2022.101649_bib21","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41467-021-21049-y","article-title":"Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2022.101649_bib22","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.1038\/ncomms7046","article-title":"Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis","volume":"6","author":"Bowes","year":"2015","journal-title":"Nat. Commun."},{"issue":"7488","key":"10.1016\/j.smim.2022.101649_bib23","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature12873","article-title":"Genetics of rheumatoid arthritis contributes to biology and drug discovery","volume":"506","author":"Okada","year":"2014","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.smim.2022.101649_bib24","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/ng.2779","article-title":"A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sj\u00f6gren's syndrome at 7q11.23","volume":"45","author":"Li","year":"2013","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.smim.2022.101649_bib25","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ng.2792","article-title":"Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sj\u00f6gren's syndrome","volume":"45","author":"Lessard","year":"2013","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.smim.2022.101649_bib26","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1136\/annrheumdis-2018-214877","article-title":"Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39,\" (in eng)","volume":"78","author":"Spiliopoulou","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.smim.2022.101649_bib27","first-page":"403","article-title":"Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis","volume":"17","author":"Bek","year":"2017","journal-title":"Pharm. J."},{"issue":"1","key":"10.1016\/j.smim.2022.101649_bib28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/ng.3459","article-title":"Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.smim.2022.101649_bib29","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/annrheumdis-2017-212403","article-title":"A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease","volume":"77","author":"Aeschlimann","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.smim.2022.101649_bib30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ng.766","article-title":"Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus","volume":"43","author":"Adrianto","year":"2011","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.smim.2022.101649_bib31","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1136\/ard.2010.146530","article-title":"A common SNP in the CD40 region is associated with systemic lupus erythematosus and correlates with altered CD40 expression: implications for the pathogenesis","volume":"70","author":"Vazgiourakis","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.smim.2022.101649_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ajhg.2014.12.024","article-title":"UBE2L3 polymorphism amplifies NF-\u03baB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases","volume":"96","author":"Lewis","year":"2015","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.smim.2022.101649_bib33","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/gene.2011.84","article-title":"Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene","volume":"13","author":"L\u00f6fgren","year":"2012","journal-title":"Genes Immun."},{"issue":"1","key":"10.1016\/j.smim.2022.101649_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41467-020-20460-1","article-title":"SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression","volume":"12","author":"Hou","year":"2021","journal-title":"Nat. Commun."},{"issue":"33","key":"10.1016\/j.smim.2022.101649_bib35","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses,\" (in eng)","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.smim.2022.101649_bib36","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.24436","article-title":"MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins","volume":"60","author":"Tang","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"16","key":"10.1016\/j.smim.2022.101649_bib37","first-page":"7024","article-title":"MiR-146a relieves kidney injury in mice with systemic lupus erythematosus through regulating NF-\u03baB pathway,\" (in eng)","volume":"23","author":"Fu","year":"2019","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.smim.2022.101649_bib38","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/art.23386","article-title":"Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis","volume":"58","author":"Stanczyk","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"6940","key":"10.1016\/j.smim.2022.101649_bib39","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nature01648","article-title":"A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression,\" (in eng)","volume":"423","author":"Anest","year":"2003","journal-title":"Nature"},{"issue":"6940","key":"10.1016\/j.smim.2022.101649_bib40","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nature01576","article-title":"Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression","volume":"423","author":"Yamamoto","year":"2003","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.smim.2022.101649_bib41","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.immuni.2016.05.013","article-title":"The costimulatory receptor OX40 inhibits Interleukin-17 expression through activation of repressive chromatin remodeling pathways","volume":"44","author":"Xiao","year":"2016","journal-title":"Immunity"},{"issue":"10055","key":"10.1016\/j.smim.2022.101649_bib42","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.smim.2022.101649_bib43","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA"},{"issue":"10271","key":"10.1016\/j.smim.2022.101649_bib44","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(20)32341-2","article-title":"Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial","volume":"397","author":"Humby","year":"2021","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.smim.2022.101649_bib45","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.celrep.2019.07.091","article-title":"Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes","volume":"28","author":"Lewis","year":"2019","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.smim.2022.101649_bib46","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","article-title":"Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry","volume":"20","author":"Zhang","year":"2019","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.smim.2022.101649_bib47","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s13075-014-0434-z","article-title":"CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic 'window of opportunity',\" (in eng)","volume":"16","author":"Greisen","year":"2014","journal-title":"Arthritis Res .Ther."},{"issue":"11","key":"10.1016\/j.smim.2022.101649_bib48","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/art.23966","article-title":"Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint","volume":"58","author":"Manzo","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.smim.2022.101649_bib49","doi-asserted-by":"crossref","first-page":"518s","DOI":"10.1042\/bst025518s","article-title":"NF-kappa B activation in human knee-joint synovial tissue during the early stage of joint inflammation","volume":"25","author":"Gilston","year":"1997","journal-title":"Biochem. Soc. Trans."},{"issue":"4","key":"10.1016\/j.smim.2022.101649_bib50","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/08916939808995367","article-title":"AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis","volume":"28","author":"Han","year":"1998","journal-title":"Autoimmunity"},{"issue":"8","key":"10.1016\/j.smim.2022.101649_bib51","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/1529-0131(200108)44:8<1897::AID-ART328>3.0.CO;2-4","article-title":"Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation","volume":"44","author":"Tak","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"26","key":"10.1016\/j.smim.2022.101649_bib52","doi-asserted-by":"crossref","first-page":"15671","DOI":"10.1073\/pnas.95.26.15671","article-title":"Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis","volume":"95","author":"Palombella","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.smim.2022.101649_bib53","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/annrheumdis-2018-214539","article-title":"Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients","volume":"78","author":"Humby","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.smim.2022.101649_bib54","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41591-022-01789-0","article-title":"Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial","volume":"28","author":"Rivellese","year":"2022","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.smim.2022.101649_bib55","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/ar4555","article-title":"Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics","volume":"16","author":"Dennis","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.smim.2022.101649_bib56","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3389\/fimmu.2020.00845","article-title":"A pauci-immune synovial pathotype predicts inadequate response to TNF\u03b1-blockade in rheumatoid arthritis patients","volume":"11","author":"Nerviani","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2022.101649_bib57","doi-asserted-by":"crossref","first-page":"953","DOI":"10.4049\/jimmunol.1401514","article-title":"Conditional deletion of NF-\u03baB-Inducing Kinase (NIK) in adult mice disrupts mature b cell survival and activation","volume":"195","author":"Brightbill","year":"2015","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2022.101649_bib58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13075-015-0527-3","article-title":"Non-canonical NF-\u03baB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?","volume":"17","author":"Noort","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"11","key":"10.1016\/j.smim.2022.101649_bib59","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/1529-0131(200111)44:11<2633::AID-ART443>3.0.CO;2-9","article-title":"Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sj\u00f6gren\u2019s syndrome","volume":"44","author":"Amft","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.smim.2022.101649_bib60","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.225615","article-title":"NIK-IKK complex interaction controls NF-\u03baB-dependent inflammatory activation of endothelium in response to LT\u03b2R ligation","volume":"132","author":"Kucharzewska","year":"2019","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.smim.2022.101649_bib61","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/cr.2010.159","article-title":"Role of NF-\u03baB in the skeleton","volume":"21","author":"Novack","year":"2011","journal-title":"Cell Res."},{"issue":"9","key":"10.1016\/j.smim.2022.101649_bib62","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/ng.874","article-title":"A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis","volume":"43","author":"Matmati","year":"2011","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.smim.2022.101649_bib63","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/nm1197-1285","article-title":"Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2","volume":"3","author":"Iotsova","year":"1997","journal-title":"Nat. Med."},{"issue":"6759","key":"10.1016\/j.smim.2022.101649_bib64","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.smim.2022.101649_bib65","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1172\/JCI23763","article-title":"NF-(kappa)B-inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritis","volume":"115","author":"Aya","year":"2005","journal-title":"J. Clin. Investig."},{"issue":"12","key":"10.1016\/j.smim.2022.101649_bib66","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1002\/art.1780381209","article-title":"Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65","volume":"38","author":"Handel","year":"1995","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.smim.2022.101649_bib67","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/art.1780390407","article-title":"Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue","volume":"39","author":"Marok","year":"1996","journal-title":"Arthritis Rheum."},{"issue":"14","key":"10.1016\/j.smim.2022.101649_bib68","doi-asserted-by":"crossref","first-page":"8211","DOI":"10.1073\/pnas.95.14.8211","article-title":"Efficient adenoviral infection with IkappaB alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappaB dependent","volume":"95","author":"Foxwell","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.smim.2022.101649_bib69","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1084\/jem.20110128","article-title":"NIK signaling in dendritic cells but not in T cells is required for the development of effector T cells and cell-mediated immune responses","volume":"208","author":"Hofmann","year":"2011","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.smim.2022.101649_bib70","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.clim.2004.12.009","article-title":"The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction","volume":"115","author":"Mor","year":"2005","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2022.101649_bib71","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/ar1958","article-title":"Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammation","volume":"8","author":"Tas","year":"2006","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.smim.2022.101649_bib72","doi-asserted-by":"crossref","first-page":"S437","DOI":"10.1016\/S0091-6749(99)70159-4","article-title":"IL-6 synthesis by rheumatoid synoviocytes is autonomously upregulated at the transcriptional level","volume":"103","author":"Miyazawa","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.smim.2022.101649_bib73","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/1529-0131(200005)43:5<1094::AID-ANR20>3.0.CO;2-V","article-title":"Gene therapy that inhibits nuclear translocation of nuclear factor kappaB results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblasts","volume":"43","author":"Zhang","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"9957","key":"10.1016\/j.smim.2022.101649_bib74","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(14)60128-8","article-title":"Systemic lupus erythematosus","volume":"384","author":"Lisnevskaia","year":"2014","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.smim.2022.101649_bib75","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.4049\/jimmunol.174.7.4043","article-title":"Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN","volume":"174","author":"Bekeredjian-Ding","year":"2005","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.smim.2022.101649_bib76","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.smim.2022.101649_bib77","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of Anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.smim.2022.101649_bib78","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"issue":"7086","key":"10.1016\/j.smim.2022.101649_bib79","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature04641","article-title":"IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9","volume":"440","author":"Hoshino","year":"2006","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.smim.2022.101649_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041644","article-title":"Aberrant CD40-induced NF-\u03baB activation in human lupus B lymphocytes","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.smim.2022.101649_bib81","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa2001180","article-title":"Two-year, randomized, controlled trial of belimumab in lupus nephritis","volume":"383","author":"Furie","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.smim.2022.101649_bib82","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.immuni.2007.07.012","article-title":"Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs","volume":"27","author":"Xie","year":"2007","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.smim.2022.101649_bib83","first-page":"2611","article-title":"Involvement of TWEAK and the NF-\u03baB signaling pathway in lupus nephritis","volume":"15","author":"Sun","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.smim.2022.101649_bib84","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41467-017-02672-0","article-title":"NF-\u03baB inducing kinase is a therapeutic target for systemic lupus erythematosus","volume":"9","author":"Brightbill","year":"2018","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.smim.2022.101649_bib85","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMcp1702514","article-title":"Primary Sj\u00f6gren's Syndrome","volume":"378","author":"Mariette","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.smim.2022.101649_bib86","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","article-title":"Increased risk of lymphoma in sicca syndrome","volume":"89","author":"Kassan","year":"1978","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.smim.2022.101649_bib87","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/534648","article-title":"Local and systemic IKK\u03b5 and NF-\u03baB signaling associated with Sj\u00f6gren's syndrome immunopathogenesis","volume":"2015","author":"Chen","year":"2015","journal-title":"J. Immunol. Res."},{"issue":"4","key":"10.1016\/j.smim.2022.101649_bib88","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/labinvest.2011.190","article-title":"Sj\u00f6gren's syndrome autoantibodies provoke changes in gene expression profiles of inflammatory cytokines triggering a pathway involving TACE\/NF-\u03baB","volume":"92","author":"Lisi","year":"2012","journal-title":"Lab Investig."},{"issue":"6","key":"10.1016\/j.smim.2022.101649_bib89","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3899\/jrheum.110097","article-title":"p38 mitogen-activated protein kinase and nuclear factor-\u03baB facilitate CD40-mediated salivary epithelial cell death","volume":"39","author":"Ping","year":"2012","journal-title":"J. Rheumatol."},{"issue":"8","key":"10.1016\/j.smim.2022.101649_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200212","article-title":"Dysregulation of NF-kB in glandular epithelial cells results in Sj\u00f6gren's-like features","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.smim.2022.101649_bib91","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/cei.12764","article-title":"Downstream activation of NF-\u03baB in the EDA-A1\/EDAR signalling in Sj\u00f6gren's syndrome and its regulation by the ubiquitin-editing enzyme A20","volume":"184","author":"Sisto","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"11","key":"10.1016\/j.smim.2022.101649_bib92","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1681\/ASN.2016060690","article-title":"Endothelial NF-\u03baB blockade abrogates ANCA-induced GN","volume":"28","author":"Choi","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.smim.2022.101649_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114017","article-title":"Experimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohorts","volume":"10","author":"Johnson","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.smim.2022.101649_bib94","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1087057115617456","article-title":"Modulation of NF-\u03baB signaling as a therapeutic target in autoimmunity","volume":"21","author":"Herrington","year":"2016","journal-title":"J. Biomol. Screen"},{"issue":"Pt 12","key":"10.1016\/j.smim.2022.101649_bib95","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1242\/jcs.00461","article-title":"NF-kappaB signalling is inhibited by glucocorticoid receptor and STAT6 via distinct mechanisms","volume":"116","author":"Nelson","year":"2003","journal-title":"J. Cell Sci."},{"issue":"5","key":"10.1016\/j.smim.2022.101649_bib96","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1053\/gast.2000.19458","article-title":"Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta","volume":"119","author":"Weber","year":"2000","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.smim.2022.101649_bib97","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.4049\/jimmunol.167.5.2911","article-title":"Methotrexate suppresses NF-kappaB activation through inhibition of IkappaBalpha phosphorylation and degradation","volume":"167","author":"Majumdar","year":"2001","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.smim.2022.101649_bib98","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.4049\/jimmunol.165.10.5962","article-title":"Leflunomide suppresses TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal protein kinase, and apoptosis","volume":"165","author":"Manna","year":"2000","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2022.101649_bib99","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1038\/s41467-021-25066-9","article-title":"Enhanced NF-\u03baB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis","volume":"12","author":"Andres-Ejarque","year":"2021","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.smim.2022.101649_bib100","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.0022-202X.2005.23735.x","article-title":"Differential expression of phosphorylated NF-kappaB\/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept","volume":"124","author":"Lizzul","year":"2005","journal-title":"J. Investig. Dermatol."},{"issue":"10\u201312","key":"10.1016\/j.smim.2022.101649_bib101","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.bbagrm.2010.05.004","article-title":"Inhibiting NF-\u03baB activation by small molecules as a therapeutic strategy","volume":"1799","author":"Gupta","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.smim.2022.101649_bib102","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13075-019-2008-6","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06650833, a selective interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, in single and multiple ascending dose randomized phase 1 studies in healthy subjects","volume":"21","author":"Danto","year":"2019","journal-title":"Arthritis Res. Ther."},{"issue":"14","key":"10.1016\/j.smim.2022.101649_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145164","article-title":"Small molecule NF-\u03baB pathway inhibitors in clinic","volume":"21","author":"Ramadass","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.smim.2022.101649_bib104","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024523","article-title":"Bortezomib in antibody-mediated autoimmune diseases (TAVAB): study protocol for a unicentric, non-randomised, non-placebo controlled trial","volume":"9","author":"Kohler","year":"2019","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.smim.2022.101649_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/cells11010009","article-title":"Discovery and early clinical development of selective immunoproteasome inhibitors","volume":"11","author":"Kirk","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.smim.2022.101649_bib106","unstructured":"A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis (PRESIDIO). \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04033926\u3009 (accessed)."},{"key":"10.1016\/j.smim.2022.101649_bib107","doi-asserted-by":"crossref","first-page":"31159","DOI":"10.1038\/srep31159","article-title":"Dimethyl fumarate blocks pro-inflammatory cytokine production via inhibition of TLR induced M1 and K63 ubiquitin chain formation","volume":"6","author":"McGuire","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.smim.2022.101649_bib108","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/bjd.14947","article-title":"Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm(\u00ae) - and placebo-controlled trial (BRIDGE)","volume":"176","author":"Mrowietz","year":"2017","journal-title":"Br. J. Dermatol."},{"issue":"12","key":"10.1016\/j.smim.2022.101649_bib109","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1177\/0961203316644335","article-title":"Fumaric acid ester treatment in cutaneous lupus erythematosus (CLE): a prospective, open-label, phase II pilot study","volume":"25","author":"Kuhn","year":"2016","journal-title":"Lupus"}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532322000665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532322000665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:22:25Z","timestamp":1760916145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532322000665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":109,"alternative-id":["S1044532322000665"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2022.101649","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diversity of NF-\u03baB signalling and inflammatory heterogeneity in Rheumatic Autoimmune Disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2022.101649","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101649"}}